These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 10887055

  • 1. First clinical trial with etomoxir in patients with chronic congestive heart failure.
    Schmidt-Schweda S, Holubarsch C.
    Clin Sci (Lond); 2000 Jul; 99(1):27-35. PubMed ID: 10887055
    [Abstract] [Full Text] [Related]

  • 2. Effects of long-term treatment with calcium antagonists on left ventricular diastolic function in stable angina and heart failure.
    Lahiri A, Rodrigues EA, Carboni GP, Raftery EB.
    Circulation; 1990 Feb; 81(2 Suppl):III130-8. PubMed ID: 2404636
    [Abstract] [Full Text] [Related]

  • 3. Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial.
    Erbs S, Linke A, Gielen S, Fiehn E, Walther C, Yu J, Adams V, Schuler G, Hambrecht R.
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):336-44. PubMed ID: 14663295
    [Abstract] [Full Text] [Related]

  • 4. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 5. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ, Davies MK.
    Br J Clin Pharmacol; 1989 Jul; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [Abstract] [Full Text] [Related]

  • 6. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H.
    Int J Cardiol; 2005 Aug 18; 103(2):182-6. PubMed ID: 16080978
    [Abstract] [Full Text] [Related]

  • 7. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
    Santostasi G, Marinato PG, Miraglia G, Egloff C, Maragno I.
    Minerva Cardioangiol; 1994 Dec 18; 42(12):575-82. PubMed ID: 7753426
    [Abstract] [Full Text] [Related]

  • 8. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR.
    Med Klin (Munich); 2003 Jan 15; 98(1):1-6. PubMed ID: 12540987
    [Abstract] [Full Text] [Related]

  • 9. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov 15; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 10. [Hemodynamic effects of one administration of l-dopa in patients with left ventricular heart failure (introductory remarks)].
    Leszek P, Zieliński T, Korewicki J.
    Kardiol Pol; 1993 May 15; 38(5):335-9. PubMed ID: 8366641
    [Abstract] [Full Text] [Related]

  • 11. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial.
    Shah SJ, Blair JE, Filippatos GS, Macarie C, Ruzyllo W, Korewicki J, Bubenek-Turconi SI, Ceracchi M, Bianchetti M, Carminati P, Kremastinos D, Grzybowski J, Valentini G, Sabbah HN, Gheorghiade M, HORIZON-HF Investigators.
    Am Heart J; 2009 Jun 15; 157(6):1035-41. PubMed ID: 19464414
    [Abstract] [Full Text] [Related]

  • 12. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN, Tsagalou EP, Nanas SN, Terrovitis JV, Tsolakis EJ, Toumanidis S, Papazoglou PD, Alexopoulos GP, Kanakakis J, Anastasiou-Nana MI.
    Int J Cardiol; 2006 Apr 04; 108(2):237-43. PubMed ID: 16183152
    [Abstract] [Full Text] [Related]

  • 13. Central and peripheral haemodynamic determinants of effort tolerance in patients with heart failure.
    Bonelli R, Etro MD, Laporta A, Colombo E, Maslowsky F, Pedretti R, Anzà C, Santoro F, Gementi A, Gronda E.
    Rev Port Cardiol; 1993 May 04; 12(5):445-53, 405, 407. PubMed ID: 8323781
    [Abstract] [Full Text] [Related]

  • 14. A non-invasive evaluation of flosequinan on haemodynamics and exercise capacity in chronic congestive heart failure.
    Motro M, Freimark D, Feinberg MS, Wynne RD, King C, Schneeweiss A.
    Int J Clin Pharmacol Res; 1993 May 04; 13(3):143-9. PubMed ID: 8225697
    [Abstract] [Full Text] [Related]

  • 15. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF, Grom E, Jähnchen E, Roskamm H.
    J Cardiovasc Pharmacol; 1989 May 04; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [Abstract] [Full Text] [Related]

  • 16. Thermal hydrotherapy improves quality of life and hemodynamic function in patients with chronic heart failure.
    Michalsen A, Lüdtke R, Bühring M, Spahn G, Langhorst J, Dobos GJ.
    Am Heart J; 2003 Oct 04; 146(4):728-33. PubMed ID: 14564334
    [Abstract] [Full Text] [Related]

  • 17. [Effect of sulmazol on left ventricular function in congestive cardiomyopathy].
    Maurer E, Klein W, Brandt D.
    Arzneimittelforschung; 1983 Oct 04; 33(5):760-3. PubMed ID: 6683555
    [Abstract] [Full Text] [Related]

  • 18. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A.
    Ital Heart J; 2004 May 04; 5(5):364-70. PubMed ID: 15185900
    [Abstract] [Full Text] [Related]

  • 19. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H.
    Growth Horm IGF Res; 2005 Apr 04; 15(2):156-64. PubMed ID: 15809020
    [Abstract] [Full Text] [Related]

  • 20. A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study.
    Holubarsch CJ, Rohrbach M, Karrasch M, Boehm E, Polonski L, Ponikowski P, Rhein S.
    Clin Sci (Lond); 2007 Aug 04; 113(4):205-12. PubMed ID: 17319797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.